Matinas BioPharma Holdings, Inc. (MTNB)
NYSEAMERICAN: MTNB · Real-Time Price · USD
0.5640
-0.0260 (-4.41%)
May 13, 2026, 4:00 PM EDT - Market closed
MTNB Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
2
Market Cap
3.61M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | 1.10M | -2.09M | -65.62% |
| Dec 31, 2022 | 3.19M | 3.16M | 9,560.61% |
| Dec 31, 2021 | 33.00K | -125.33K | -79.16% |
| Dec 31, 2020 | 158.33K | 68.52K | 76.29% |
| Dec 31, 2019 | 89.81K | -29.94K | -25.00% |
| Dec 31, 2018 | 119.75K | -29.94K | -20.00% |
| Dec 31, 2017 | 149.69K | - | - |
| Dec 31, 2016 | - | - | - |
| Dec 31, 2015 | 194.49K | - | - |
| Dec 31, 2014 | - | - | - |
| Dec 31, 2013 | - | - | - |
| Dec 31, 2012 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Ensysce Biosciences | 5.07M |
| GeoVax Labs | 2.49M |
| 60 Degrees Pharmaceuticals | 1.41M |
| VivoSim Labs | 142.00K |
| Azitra | 7.50K |
| Pulmatrix | 3.00K |
MTNB News
- 5 weeks ago - Matinas BioPharma Receives Notice of Non-Compliance with NYSE American Continued Listing Standards - GlobeNewsWire
- 1 year ago - Matinas BioPharma files to sell 16.9M shares of common stock for holders - TheFly
- 1 year ago - Matinas BioPharma appoints Murphy, Neugeboren to board of directors - TheFly
- 1 year ago - Matinas BioPharma Appoints Seasoned Biotech Leaders to Board of Directors - GlobeNewsWire
- 1 year ago - Matinas BioPharma Announces Agreement for the Acquisition of Preferred Stock and Appointment of Dr. Robin L. Smith to the Board of Directors - GlobeNewsWire
- 1 year ago - Matinas BioPharma appoints Evelyn D’An to board of directors - TheFly
- 1 year ago - Matinas BioPharma Appoints Evelyn D'An to Board of Directors as Audit Committee Chair - GlobeNewsWire
- 1 year ago - Matinas BioPharma receives NYSE noncompliance notice - TheFly